Our Specialists are committed to helping patients get their prescribed Celgene medications, no matter what their insurance situation.
Depending on a patient’s insurance situation, there are programs and organizations that may help pay for the prescribed Celgene medication.
Our Specialists are available to assist with each of the following steps in the insurance approval process for prescribed Celgene medications*
If you prefer, you can download and print the Celgene Healthcare Professional Support brochure for quick reference. The brochure contains all the information you need about patient financial assistance and our insurance-related support for Celgene medications.
*Other eligibility requirements and restrictions apply. Please see full Terms and Conditions.
†Patients must meet specified financial and insurance Eligibility Requirements to qualify for assistance.
REVLIMID® (lenalidomide) and POMALYST® (pomalidomide) are only available through restricted distribution programs.
Please see full Prescribing Information, including Boxed WARNINGS, for REVLIMID®, POMALYST®, IDHIFA® (enasidenib), INREBIC® (fedratinib), and ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Please see full prescribing information for REBLOZYL® (luspatercept-aamt).
Your Specialist is assigned based on the zip code of your office. To meet your Specialist, enter your zip code below.
This website is intended for
US healthcare professionals only
The ICD-10-CM Codes provided here are for diagnoses reasonably related to an indication or indications within the product’s approved label and are provided for your reference only. Other codes may be appropriate. Celgene makes no representation that any code is appropriate for a particular patient. Healthcare Professionals must use their independent judgment in selecting Code(s) to accurately reflect the diagnosis of the specific patient.